Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools”) and Treeline Biosciences, Inc. (“Treeline”) announce they have entered into a definitive merger agreement to combine in an all-stock transaction. Upon completion of the transaction, which is expected to occur in the second half of 2026, the combined company is expected to operate under the name Treeline Biosciences and trade on the Nasdaq under the ticker symbol “TRLN.” The transaction, which is structured to be tax-free to Standard BioTools and Treeline shareholders, values Standard BioTools at net cash delivered at closing plus $10 million, which is estimated to be $460 million.
Read the full article: Standard BioTools and Treeline Biosciences Announce Merger Agreement //
Source: https://www.globenewswire.com/news-release/2026/06/08/3307989/0/en/standard-biotools-and-treeline-biosciences-announce-merger-agreement.html